CLARIVATE PLC
CLVTNYSETrading Snapshot
- Day Range
- $181.97 – $185.99
- 52-Week Range
- $1.66 – $3.96
- Volume
- $2.55B
- Avg Volume
- $2.99B
- Shares Outstanding
- 639.7M
- Next Earnings
- Nov 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.46B
- Last Q Revenue
- $587M
- P/E Ratio
- -3.3
- P/S Ratio
- 0.5x
- EPS (TTM)
- $-0.52
- Dividend Yield
- 0.00%
- Dilution (1yr)
- −5.8%
Why Investors Own CLVT
- ✓High-growth profile — revenue up +24.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 25% gross margin and 18% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CLARIVATE PLC
CLVT
StockOtter · stockotter.spaceAbout CLARIVATE PLC
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
CLARIVATE PLC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift CLVT price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CLARIVATE PLC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.